 Lori Walker
Concepts (416)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Dysfunction, Right | 6 | 2023 | 228 | 2.190 |
Why?
| | Heart Ventricles | 11 | 2023 | 727 | 1.910 |
Why?
| | Myocardium | 18 | 2017 | 970 | 1.860 |
Why?
| | Troponin I | 11 | 2019 | 83 | 1.420 |
Why?
| | Myocytes, Cardiac | 12 | 2019 | 472 | 1.070 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2023 | 146 | 1.050 |
Why?
| | Ventricular Function, Right | 5 | 2023 | 257 | 1.030 |
Why?
| | Hypertension, Pulmonary | 8 | 2023 | 1794 | 1.020 |
Why?
| | Myocardial Infarction | 10 | 2022 | 968 | 1.010 |
Why?
| | Cattle | 6 | 2023 | 978 | 0.860 |
Why?
| | Actin Cytoskeleton | 7 | 2011 | 100 | 0.810 |
Why?
| | Phosphorylation | 25 | 2019 | 1633 | 0.750 |
Why?
| | Myosin Light Chains | 8 | 2013 | 35 | 0.730 |
Why?
| | Protein Processing, Post-Translational | 6 | 2016 | 408 | 0.710 |
Why?
| | Cell Dedifferentiation | 1 | 2019 | 30 | 0.710 |
Why?
| | Myocardial Contraction | 11 | 2019 | 339 | 0.650 |
Why?
| | Disease Models, Animal | 11 | 2023 | 3730 | 0.630 |
Why?
| | Fibroblasts | 2 | 2019 | 842 | 0.600 |
Why?
| | Calcium | 16 | 2019 | 1169 | 0.600 |
Why?
| | Ventricular Remodeling | 7 | 2023 | 229 | 0.590 |
Why?
| | Muscle Proteins | 4 | 2011 | 219 | 0.580 |
Why?
| | Muscle, Smooth | 8 | 2007 | 157 | 0.580 |
Why?
| | Cardiac Myosins | 3 | 2013 | 33 | 0.560 |
Why?
| | Myocardial Ischemia | 4 | 2022 | 251 | 0.550 |
Why?
| | Period Circadian Proteins | 5 | 2021 | 22 | 0.530 |
Why?
| | Cardiomegaly | 2 | 2013 | 168 | 0.520 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2012 | 374 | 0.510 |
Why?
| | Interleukin-18 | 1 | 2016 | 228 | 0.490 |
Why?
| | Mitochondria | 2 | 2020 | 786 | 0.460 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2012 | 10 | 0.430 |
Why?
| | Blotting, Western | 3 | 2015 | 1194 | 0.420 |
Why?
| | Heart Failure | 7 | 2023 | 1969 | 0.410 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2016 | 454 | 0.410 |
Why?
| | Antibodies | 2 | 2013 | 392 | 0.410 |
Why?
| | Animals | 48 | 2023 | 33381 | 0.400 |
Why?
| | Hypoxia | 3 | 2023 | 963 | 0.400 |
Why?
| | Protein Kinase C | 5 | 2014 | 297 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1798 | 0.360 |
Why?
| | Phenotype | 6 | 2013 | 3003 | 0.360 |
Why?
| | Aortic Valve Stenosis | 1 | 2013 | 295 | 0.340 |
Why?
| | Muscle Contraction | 8 | 2014 | 413 | 0.340 |
Why?
| | Myosin Heavy Chains | 4 | 2017 | 192 | 0.330 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 248 | 0.300 |
Why?
| | Aorta | 3 | 2018 | 367 | 0.300 |
Why?
| | Exercise | 1 | 2018 | 1657 | 0.300 |
Why?
| | Gene Expression | 5 | 2016 | 1489 | 0.260 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 502 | 0.250 |
Why?
| | Heart | 3 | 2017 | 631 | 0.240 |
Why?
| | Serine | 3 | 2013 | 138 | 0.240 |
Why?
| | Receptor, Adenosine A2B | 2 | 2015 | 32 | 0.240 |
Why?
| | Signal Transduction | 12 | 2020 | 4709 | 0.230 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 246 | 0.210 |
Why?
| | rho-Associated Kinases | 2 | 2015 | 84 | 0.210 |
Why?
| | Mice | 20 | 2017 | 15520 | 0.200 |
Why?
| | Protein-Tyrosine Kinases | 5 | 1999 | 407 | 0.200 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2017 | 192 | 0.200 |
Why?
| | Point Mutation | 2 | 2001 | 228 | 0.200 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2019 | 344 | 0.190 |
Why?
| | Circadian Clocks | 1 | 2021 | 48 | 0.190 |
Why?
| | Tachycardia, Ventricular | 1 | 2022 | 151 | 0.180 |
Why?
| | Catechin | 1 | 2020 | 26 | 0.180 |
Why?
| | rhoA GTP-Binding Protein | 5 | 2008 | 80 | 0.180 |
Why?
| | Rats | 10 | 2018 | 5392 | 0.180 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 4 | 2011 | 140 | 0.180 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2445 | 0.180 |
Why?
| | MicroRNAs | 3 | 2017 | 637 | 0.180 |
Why?
| | Electron Transport Complex I | 2 | 2020 | 36 | 0.170 |
Why?
| | Male | 27 | 2022 | 57801 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2021 | 276 | 0.170 |
Why?
| | Isoflavones | 4 | 1995 | 24 | 0.160 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 356 | 0.160 |
Why?
| | Glycolysis | 2 | 2017 | 224 | 0.160 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 39 | 0.160 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 75 | 0.160 |
Why?
| | Isoenzymes | 1 | 1998 | 297 | 0.150 |
Why?
| | Vasoconstriction | 2 | 2018 | 213 | 0.150 |
Why?
| | Carotid Arteries | 1 | 2018 | 184 | 0.150 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2015 | 105 | 0.140 |
Why?
| | Protein Kinase C-epsilon | 4 | 2006 | 31 | 0.140 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 204 | 0.140 |
Why?
| | Up-Regulation | 2 | 2017 | 872 | 0.140 |
Why?
| | Carrier Proteins | 4 | 2019 | 726 | 0.140 |
Why?
| | Swine | 3 | 2013 | 730 | 0.140 |
Why?
| | Protein Phosphatase 1 | 2 | 2013 | 32 | 0.140 |
Why?
| | Chemokine CXCL12 | 1 | 2016 | 80 | 0.140 |
Why?
| | Protein Phosphatase 2 | 2 | 2013 | 35 | 0.140 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 12 | 0.130 |
Why?
| | Hemodynamics | 2 | 2011 | 1004 | 0.130 |
Why?
| | Cannabis | 1 | 2022 | 382 | 0.130 |
Why?
| | Humans | 24 | 2022 | 118974 | 0.130 |
Why?
| | Phenylephrine | 5 | 2014 | 85 | 0.130 |
Why?
| | Calcium Signaling | 3 | 2014 | 219 | 0.130 |
Why?
| | Amino Acid Substitution | 3 | 2009 | 276 | 0.130 |
Why?
| | Phosphofructokinase-1 | 1 | 2014 | 7 | 0.130 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 160 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2016 | 2680 | 0.130 |
Why?
| | Mitochondria, Muscle | 1 | 2016 | 97 | 0.130 |
Why?
| | Glucose Transporter Type 4 | 1 | 2014 | 38 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 85 | 0.130 |
Why?
| | Anion Transport Proteins | 1 | 2014 | 12 | 0.130 |
Why?
| | Circadian Rhythm | 2 | 2021 | 401 | 0.130 |
Why?
| | Cells, Cultured | 5 | 2019 | 4077 | 0.120 |
Why?
| | Myosin-Light-Chain Kinase | 4 | 2006 | 26 | 0.120 |
Why?
| | Light | 1 | 2017 | 342 | 0.120 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 211 | 0.120 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 46 | 0.120 |
Why?
| | Angiotensin II | 1 | 2014 | 107 | 0.120 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 236 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 167 | 0.120 |
Why?
| | GTP-Binding Proteins | 3 | 1999 | 147 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2020 | 1178 | 0.120 |
Why?
| | Antibody Specificity | 1 | 2013 | 184 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 907 | 0.120 |
Why?
| | Collagen | 1 | 2016 | 433 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2017 | 4908 | 0.110 |
Why?
| | RNA, Messenger | 5 | 2014 | 2657 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 462 | 0.110 |
Why?
| | Palmitic Acid | 1 | 2012 | 38 | 0.110 |
Why?
| | Models, Biological | 1 | 2020 | 1715 | 0.110 |
Why?
| | Immunodominant Epitopes | 1 | 2012 | 27 | 0.110 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2012 | 47 | 0.110 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 34 | 0.110 |
Why?
| | Protein Array Analysis | 1 | 2012 | 63 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 527 | 0.100 |
Why?
| | Guanine Nucleotide Dissociation Inhibitors | 3 | 2000 | 5 | 0.100 |
Why?
| | Monocrotaline | 2 | 2008 | 35 | 0.100 |
Why?
| | src-Family Kinases | 1 | 2012 | 90 | 0.100 |
Why?
| | Ventricular Pressure | 1 | 2011 | 41 | 0.100 |
Why?
| | Excitation Contraction Coupling | 1 | 2011 | 18 | 0.100 |
Why?
| | Hyperbaric Oxygenation | 1 | 2011 | 39 | 0.100 |
Why?
| | Protein Kinases | 3 | 2020 | 310 | 0.100 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2010 | 6 | 0.100 |
Why?
| | Desmin | 1 | 2010 | 31 | 0.100 |
Why?
| | Antigen Presentation | 1 | 2012 | 194 | 0.100 |
Why?
| | Myofibrils | 1 | 2011 | 50 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 177 | 0.100 |
Why?
| | Fatty Acids | 1 | 2013 | 407 | 0.090 |
Why?
| | Autophagy | 1 | 2014 | 315 | 0.090 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2012 | 200 | 0.090 |
Why?
| | Histone Deacetylases | 1 | 2012 | 198 | 0.090 |
Why?
| | Microcystins | 2 | 2001 | 9 | 0.090 |
Why?
| | Recovery of Function | 2 | 2011 | 604 | 0.090 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2010 | 144 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 241 | 0.090 |
Why?
| | Tyrosine | 3 | 1995 | 233 | 0.090 |
Why?
| | Bisoprolol | 1 | 2009 | 5 | 0.090 |
Why?
| | Rats, Wistar | 3 | 2018 | 399 | 0.090 |
Why?
| | Biopsy | 1 | 2013 | 1079 | 0.090 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2009 | 17 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2011 | 806 | 0.080 |
Why?
| | Time Factors | 6 | 2012 | 6412 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 83 | 0.080 |
Why?
| | Isoelectric Focusing | 2 | 2006 | 38 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1868 | 0.080 |
Why?
| | Rabbits | 5 | 2001 | 780 | 0.080 |
Why?
| | Peptide Fragments | 4 | 2018 | 702 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2013 | 2874 | 0.080 |
Why?
| | Peptides | 3 | 2001 | 879 | 0.080 |
Why?
| | Dehydroepiandrosterone | 1 | 2008 | 50 | 0.080 |
Why?
| | Peptides, Cyclic | 2 | 2001 | 260 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2071 | 0.080 |
Why?
| | Superoxides | 2 | 2020 | 221 | 0.080 |
Why?
| | Nitriles | 2 | 1995 | 155 | 0.080 |
Why?
| | Female | 11 | 2022 | 61565 | 0.080 |
Why?
| | Smooth Muscle Myosins | 1 | 2007 | 9 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1781 | 0.080 |
Why?
| | Ileum | 3 | 2001 | 100 | 0.080 |
Why?
| | In Vitro Techniques | 6 | 2011 | 1094 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2012 | 767 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2871 | 0.070 |
Why?
| | Cardiac Output, Low | 1 | 2007 | 68 | 0.070 |
Why?
| | Echocardiography | 1 | 2009 | 556 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 207 | 0.070 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 301 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 420 | 0.070 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 4 | 2000 | 18 | 0.070 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2006 | 107 | 0.070 |
Why?
| | Portal Vein | 4 | 2000 | 90 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2013 | 3171 | 0.070 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1284 | 0.070 |
Why?
| | Hypercapnia | 1 | 2005 | 50 | 0.070 |
Why?
| | Ventricular Function, Left | 2 | 2006 | 468 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2011 | 485 | 0.060 |
Why?
| | Muscle Relaxation | 2 | 2001 | 32 | 0.060 |
Why?
| | Phosphoserine | 1 | 2004 | 34 | 0.060 |
Why?
| | Systole | 1 | 2005 | 168 | 0.060 |
Why?
| | Down-Regulation | 2 | 1998 | 627 | 0.060 |
Why?
| | Urinary Bladder | 1 | 2007 | 180 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2023 | 732 | 0.060 |
Why?
| | Genistein | 4 | 1995 | 20 | 0.060 |
Why?
| | Disease Progression | 2 | 2009 | 2490 | 0.060 |
Why?
| | Colforsin | 2 | 2001 | 55 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2275 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1816 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 940 | 0.060 |
Why?
| | Vanadates | 1 | 1993 | 29 | 0.060 |
Why?
| | Mice, Transgenic | 5 | 2007 | 2025 | 0.060 |
Why?
| | Serotonin | 1 | 1995 | 309 | 0.060 |
Why?
| | Tyrphostins | 1 | 1993 | 16 | 0.060 |
Why?
| | Biomarkers | 1 | 2013 | 3588 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2674 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 4 | 2012 | 2478 | 0.060 |
Why?
| | Catecholamines | 2 | 2014 | 100 | 0.050 |
Why?
| | Inflammation | 1 | 2013 | 2566 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1691 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 101 | 0.050 |
Why?
| | Potassium Chloride | 2 | 2014 | 41 | 0.050 |
Why?
| | Culture Techniques | 1 | 2001 | 80 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 2 | 1999 | 57 | 0.050 |
Why?
| | Cyclic GMP | 1 | 2001 | 109 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2001 | 86 | 0.050 |
Why?
| | Sarcomeres | 2 | 2011 | 91 | 0.050 |
Why?
| | Binding Sites | 2 | 2001 | 1224 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2001 | 413 | 0.050 |
Why?
| | Antimycin A | 1 | 2020 | 13 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 44 | 0.050 |
Why?
| | Cell Respiration | 1 | 2020 | 76 | 0.050 |
Why?
| | Immunoassay | 1 | 2000 | 101 | 0.050 |
Why?
| | Guanosine Triphosphate | 1 | 2000 | 87 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2009 | 828 | 0.050 |
Why?
| | Guinea Pigs | 3 | 1995 | 151 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 277 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 95 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1999 | 8 | 0.040 |
Why?
| | Nitric Oxide | 2 | 2016 | 892 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1999 | 30 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2020 | 60 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 198 | 0.040 |
Why?
| | Middle Aged | 4 | 2013 | 27617 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2012 | 290 | 0.040 |
Why?
| | Phosphotransferases | 1 | 1999 | 27 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 116 | 0.040 |
Why?
| | Kinetics | 3 | 2011 | 1624 | 0.040 |
Why?
| | Integrins | 1 | 1999 | 82 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 175 | 0.040 |
Why?
| | Myosin-Light-Chain Phosphatase | 1 | 1998 | 4 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2000 | 292 | 0.040 |
Why?
| | Ferrets | 1 | 1998 | 21 | 0.040 |
Why?
| | ras Proteins | 1 | 1999 | 141 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1998 | 67 | 0.040 |
Why?
| | ADP Ribose Transferases | 1 | 1997 | 10 | 0.040 |
Why?
| | Dobutamine | 2 | 2010 | 36 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 76 | 0.040 |
Why?
| | Blood Pressure | 3 | 2012 | 1664 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 1997 | 63 | 0.040 |
Why?
| | Adenosine Diphosphate | 1 | 1997 | 88 | 0.040 |
Why?
| | Phosphofructokinases | 1 | 2017 | 2 | 0.040 |
Why?
| | Pyrans | 1 | 1997 | 4 | 0.040 |
Why?
| | Spiro Compounds | 1 | 1997 | 10 | 0.040 |
Why?
| | Botulinum Toxins | 1 | 1997 | 40 | 0.040 |
Why?
| | Ischemic Preconditioning | 1 | 2017 | 29 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 876 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 1945 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2018 | 233 | 0.040 |
Why?
| | Aged | 2 | 2013 | 19657 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2015 | 18 | 0.030 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 57 | 0.030 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 2015 | 31 | 0.030 |
Why?
| | rho-Specific Guanine Nucleotide Dissociation Inhibitors | 3 | 2000 | 3 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 95 | 0.030 |
Why?
| | Vasodilation | 1 | 2018 | 457 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 953 | 0.030 |
Why?
| | Recombinant Proteins | 3 | 2006 | 1308 | 0.030 |
Why?
| | Cell Movement | 1 | 1999 | 896 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 204 | 0.030 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2014 | 22 | 0.030 |
Why?
| | Phosphotyrosine | 2 | 1995 | 37 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2015 | 220 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 120 | 0.030 |
Why?
| | Organ Specificity | 1 | 2015 | 278 | 0.030 |
Why?
| | Chromosome Duplication | 1 | 2014 | 4 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1998 | 827 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2014 | 30 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 273 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2014 | 122 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 361 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 219 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 97 | 0.030 |
Why?
| | Lactates | 1 | 2013 | 87 | 0.030 |
Why?
| | Vascular Stiffness | 1 | 2018 | 425 | 0.030 |
Why?
| | Dogs | 2 | 1995 | 371 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 483 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 409 | 0.030 |
Why?
| | Malonyl Coenzyme A | 1 | 2012 | 6 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 180 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2012 | 9 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2012 | 38 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 1 | 2012 | 59 | 0.030 |
Why?
| | Action Potentials | 1 | 2015 | 420 | 0.030 |
Why?
| | Sunlight | 1 | 2013 | 60 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2013 | 122 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 139 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2174 | 0.030 |
Why?
| | Cardioplegic Solutions | 1 | 2011 | 6 | 0.030 |
Why?
| | Phosphorus Radioisotopes | 1 | 2011 | 29 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 154 | 0.030 |
Why?
| | Buffers | 1 | 2011 | 56 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 176 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 770 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 508 | 0.020 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor alpha | 2 | 2000 | 2 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 418 | 0.020 |
Why?
| | Neutrophils | 1 | 2015 | 1233 | 0.020 |
Why?
| | Connectin | 1 | 2009 | 26 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 65 | 0.020 |
Why?
| | Detergents | 2 | 2000 | 44 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 121 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 982 | 0.020 |
Why?
| | Troponin T | 1 | 2009 | 50 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 10793 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 159 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 382 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 439 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 280 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 653 | 0.020 |
Why?
| | Stroke Volume | 1 | 2011 | 513 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| | Cytosol | 2 | 1999 | 221 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 460 | 0.020 |
Why?
| | Phorbol 12,13-Dibutyrate | 2 | 1997 | 11 | 0.020 |
Why?
| | Precipitin Tests | 2 | 1997 | 93 | 0.020 |
Why?
| | Contractile Proteins | 1 | 2007 | 17 | 0.020 |
Why?
| | Adult | 3 | 2017 | 31512 | 0.020 |
Why?
| | Endothelins | 2 | 1997 | 62 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2007 | 74 | 0.020 |
Why?
| | Protein Kinase C-alpha | 1 | 2007 | 43 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 115 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1882 | 0.020 |
Why?
| | Kidney | 1 | 2014 | 1353 | 0.020 |
Why?
| | Troponin C | 1 | 2006 | 6 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1597 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 647 | 0.020 |
Why?
| | Pressure | 1 | 2007 | 226 | 0.020 |
Why?
| | Fura-2 | 1 | 1995 | 21 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2007 | 345 | 0.020 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 1995 | 32 | 0.020 |
Why?
| | Receptors, Serotonin | 1 | 1995 | 33 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 2 | 2000 | 495 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9491 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1267 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 1900 | 0.020 |
Why?
| | Propranolol | 1 | 2005 | 54 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2005 | 69 | 0.020 |
Why?
| | Protein Kinase C beta | 1 | 2004 | 26 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2011 | 671 | 0.020 |
Why?
| | Diastole | 1 | 2005 | 145 | 0.020 |
Why?
| | Actins | 1 | 2007 | 404 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2004 | 94 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 823 | 0.020 |
Why?
| | Osteopontin | 1 | 2004 | 39 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 146 | 0.020 |
Why?
| | Body Weight | 1 | 2009 | 934 | 0.020 |
Why?
| | Lung | 1 | 2017 | 3664 | 0.020 |
Why?
| | Muscle Strength | 1 | 2007 | 283 | 0.020 |
Why?
| | Acidosis | 1 | 2005 | 86 | 0.020 |
Why?
| | Mutation | 2 | 2009 | 3457 | 0.020 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 162 | 0.020 |
Why?
| | Femoral Artery | 1 | 1995 | 175 | 0.020 |
Why?
| | Stroke | 1 | 2013 | 1047 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2005 | 217 | 0.010 |
Why?
| | Drug Resistance | 1 | 2004 | 167 | 0.010 |
Why?
| | Intestine, Large | 1 | 1993 | 15 | 0.010 |
Why?
| | Cardiotonic Agents | 1 | 2004 | 127 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1541 | 0.010 |
Why?
| | Carbachol | 1 | 1993 | 20 | 0.010 |
Why?
| | Catechols | 1 | 1993 | 16 | 0.010 |
Why?
| | Quinones | 1 | 1993 | 11 | 0.010 |
Why?
| | Myosins | 1 | 1993 | 130 | 0.010 |
Why?
| | Protein Binding | 2 | 1999 | 1975 | 0.010 |
Why?
| | Lactams, Macrocyclic | 1 | 1993 | 47 | 0.010 |
Why?
| | Benzoquinones | 1 | 1993 | 44 | 0.010 |
Why?
| | Potassium | 1 | 1993 | 132 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1158 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2008 | 1063 | 0.010 |
Why?
| | Cyclic GMP-Dependent Protein Kinases | 1 | 2000 | 5 | 0.010 |
Why?
| | Octoxynol | 1 | 2000 | 12 | 0.010 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2000 | 8 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 2000 | 20 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2000 | 73 | 0.010 |
Why?
| | Child | 1 | 2019 | 19129 | 0.010 |
Why?
| | Cell Line | 1 | 2006 | 2707 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 2000 | 105 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2000 | 141 | 0.010 |
Why?
| | Vitronectin | 1 | 1999 | 5 | 0.010 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 1999 | 14 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 201 | 0.010 |
Why?
| | GTP Phosphohydrolases | 1 | 1999 | 69 | 0.010 |
Why?
| | Flavonoids | 1 | 1999 | 71 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1999 | 67 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 183 | 0.010 |
Why?
| | Liposomes | 1 | 2000 | 151 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 338 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 1997 | 20 | 0.010 |
Why?
| | Crystallography, X-Ray | 1 | 1999 | 422 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1999 | 443 | 0.010 |
Why?
| | Oligopeptides | 1 | 1999 | 252 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 874 | 0.010 |
Why?
| | Aluminum Compounds | 1 | 1997 | 7 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 1999 | 367 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1999 | 397 | 0.010 |
Why?
| | Fluorides | 1 | 1997 | 47 | 0.010 |
Why?
| | Hemolysin Proteins | 1 | 1997 | 33 | 0.010 |
Why?
| | Biological Transport | 1 | 1997 | 382 | 0.010 |
Why?
| | Solubility | 1 | 1997 | 235 | 0.010 |
Why?
| | Protein Conformation | 1 | 1999 | 848 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 1997 | 106 | 0.010 |
Why?
| | Isometric Contraction | 1 | 1997 | 155 | 0.010 |
Why?
| | Antifungal Agents | 1 | 1997 | 134 | 0.010 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 237 | 0.010 |
Why?
| | Aging | 1 | 2006 | 1670 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2011 | 12978 | 0.010 |
Why?
| | Cell Membrane | 1 | 1997 | 710 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1323 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 18480 | 0.010 |
Why?
|
|
Walker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|